Aditxt (ADTX) Net Income towards Common Stockholders (QoQ) (2019 - 2026)
Aditxt (ADTX) Net Income towards Common Stockholders (QoQ) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Aditxt |
2,485.68 |
-2.16 Mn |
2,868.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-209.47% |
| Dec 31, 2025 |
78.39% |
| Sep 30, 2025 |
-227.32% |
| Jun 30, 2025 |
-24.25% |
| Mar 31, 2025 |
-7.31% |
| Dec 31, 2024 |
20.53% |
| Sep 30, 2024 |
8.44% |
| Jun 30, 2024 |
48.73% |
| Mar 31, 2024 |
-33.70% |
| Dec 31, 2023 |
-12.18% |
| Sep 30, 2023 |
-74.46% |
| Jun 30, 2023 |
5.06% |
| Mar 31, 2023 |
27.20% |
| Dec 31, 2022 |
-8.78% |
| Sep 30, 2022 |
-321.16% |
| Jun 30, 2022 |
70.38% |
| Mar 31, 2022 |
74.81% |
| Dec 31, 2021 |
-146.42% |
| Sep 30, 2021 |
-57.98% |
| Jun 30, 2021 |
3.15% |
